vs
Side-by-side financial comparison of Beam Global (BEEM) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $9.0M, roughly 1.5× Beam Global). Beam Global runs the higher net margin — -25.8% vs -34.7%, a 9.0% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 6.7%). Over the past eight quarters, Beam Global's revenue compounded faster (-21.2% CAGR vs -26.3%).
Suntory Global Spirits Inc., formerly known as Beam Suntory, Inc., and before that as Beam, Inc., is an American beverage company that is a subsidiary of Suntory Holdings, a Japanese multinational beverage conglomerate. The company produces alcoholic beverages.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
BEEM vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.0M | $13.8M |
| Net Profit | $-2.3M | $-4.8M |
| Gross Margin | 17.8% | — |
| Operating Margin | -29.3% | -18.5% |
| Net Margin | -25.8% | -34.7% |
| Revenue YoY | 6.7% | 73.8% |
| Net Profit YoY | 49.6% | -141.1% |
| EPS (diluted) | — | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.0M | $13.8M | ||
| Q3 25 | $5.8M | $12.5M | ||
| Q2 25 | $7.1M | $9.7M | ||
| Q1 25 | $6.3M | $8.8M | ||
| Q4 24 | $8.5M | $7.9M | ||
| Q3 24 | $11.5M | $7.0M | ||
| Q2 24 | $14.8M | $7.3M | ||
| Q1 24 | $14.6M | $25.4M |
| Q4 25 | $-2.3M | $-4.8M | ||
| Q3 25 | $-4.9M | $-638.0K | ||
| Q2 25 | $-4.3M | $-3.2M | ||
| Q1 25 | $-15.5M | $-1.2M | ||
| Q4 24 | $-4.6M | $-2.0M | ||
| Q3 24 | $1.3M | $-5.7M | ||
| Q2 24 | $-4.9M | $-5.6M | ||
| Q1 24 | $-3.0M | $12.8M |
| Q4 25 | 17.8% | — | ||
| Q3 25 | -0.5% | — | ||
| Q2 25 | 20.3% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | 15.9% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | -29.3% | -18.5% | ||
| Q3 25 | -84.2% | -1.5% | ||
| Q2 25 | -63.1% | -28.3% | ||
| Q1 25 | -245.8% | -9.2% | ||
| Q4 24 | -60.1% | -11.8% | ||
| Q3 24 | 11.2% | -74.6% | ||
| Q2 24 | -32.3% | -69.4% | ||
| Q1 24 | -20.9% | 54.2% |
| Q4 25 | -25.8% | -34.7% | ||
| Q3 25 | -84.1% | -5.1% | ||
| Q2 25 | -60.5% | -32.7% | ||
| Q1 25 | -245.5% | -13.3% | ||
| Q4 24 | -54.5% | -25.0% | ||
| Q3 24 | 11.3% | -82.2% | ||
| Q2 24 | -33.2% | -76.5% | ||
| Q1 24 | -20.9% | 50.6% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.28 | $-0.02 | ||
| Q2 25 | $-0.28 | $-0.11 | ||
| Q1 25 | $-1.04 | $-0.04 | ||
| Q4 24 | $-0.31 | $-0.02 | ||
| Q3 24 | $0.09 | $-0.21 | ||
| Q2 24 | $-0.34 | $-0.20 | ||
| Q1 24 | $-0.21 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $969.0K | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $24.8M | $35.5M |
| Total Assets | $42.7M | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $969.0K | $36.8M | ||
| Q3 25 | $3.3M | $21.9M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | — | $22.7M | ||
| Q4 24 | $4.6M | $26.6M | ||
| Q3 24 | — | $40.3M | ||
| Q2 24 | — | $43.1M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $24.8M | $35.5M | ||
| Q3 25 | $26.5M | $-4.5M | ||
| Q2 25 | $26.9M | $-7.5M | ||
| Q1 25 | $26.7M | $-5.9M | ||
| Q4 24 | $41.3M | $-5.9M | ||
| Q3 24 | $46.4M | $-5.2M | ||
| Q2 24 | $43.4M | $-1.4M | ||
| Q1 24 | $46.9M | $3.0M |
| Q4 25 | $42.7M | $70.6M | ||
| Q3 25 | $44.6M | $49.3M | ||
| Q2 25 | $46.7M | $44.9M | ||
| Q1 25 | $46.8M | $46.4M | ||
| Q4 24 | $61.5M | $44.9M | ||
| Q3 24 | $67.3M | $58.9M | ||
| Q2 24 | $71.9M | $63.2M | ||
| Q1 24 | $75.7M | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | $-6.0M |
| Free Cash FlowOCF − Capex | $-3.8M | — |
| FCF MarginFCF / Revenue | -42.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.8M | $-6.0M | ||
| Q3 25 | $-4.6M | $1.5M | ||
| Q2 25 | $-318.0K | $-3.7M | ||
| Q1 25 | $-1.8M | $-4.3M | ||
| Q4 24 | $859.0K | $-1.5M | ||
| Q3 24 | $-3.0M | $-2.2M | ||
| Q2 24 | $2.9M | $-8.4M | ||
| Q1 24 | $-3.0M | $39.0M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-5.1M | — | ||
| Q2 25 | $-1.1M | — | ||
| Q1 25 | $-1.8M | — | ||
| Q4 24 | $462.0K | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $-3.1M | — |
| Q4 25 | -42.3% | — | ||
| Q3 25 | -87.9% | — | ||
| Q2 25 | -15.2% | — | ||
| Q1 25 | -28.7% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | -27.4% | — | ||
| Q2 24 | 18.9% | — | ||
| Q1 24 | -21.5% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 7.8% | — | ||
| Q2 25 | 10.7% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.28× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BEEM
| Products | $7.0M | 77% |
| Other | $2.0M | 23% |
FENC
Segment breakdown not available.
